Veradermics, Incorporated
MANENYSEHealthcare · Pharmaceutical Preparations
Market cap
$4.40B
Employees
21
Exchange
NYSE
Headquarters
NEW HAVEN, CT
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.